Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Acute hepatitis B with delta-agent (coinfection) with hepatic coma |
French
|
Hépatite aiguë B avec agent delta, avec coma hépatique |
| Level | Code | Title | |
|---|---|---|---|
| 1 | I | Certain infectious and parasitic diseases | |
| 2 | B15-B19 | Viral hepatitis | |
| 3 | B16 | Acute hepatitis B | |
| 4 | B16.0 | Acute hepatitis B with delta-agent (coinfection) with hepatic coma |
| Active Ingredient | Description | |
|---|---|---|
| Human hepatitis B immunoglobulin |
Human hepatitis B immunoglobulin solution for infusion contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against hepatitis B virus surface antigen (HBs). It is used for the immunoprophylaxis of hepatitis B and the prevention of hepatitis B virus re-infection after liver transplantation for hepatitis B induced liver failure. |
|
| Tenofovir disoproxil |
Tenofovir disoproxil is absorbed and converted to the active substance tenofovir, which is a nucleoside monophosphate analogue. Tenofovir is then converted to the active metabolite, tenofovir diphosphate, an obligate chain terminator, by constitutively expressed cellular enzymes. Tenofovir diphosphate inhibits HIV-1 reverse transcriptase and the HBV polymerase by direct binding competition with the natural deoxyribonucleotide substrate and, after incorporation into DNA, by DNA chain termination. |
